| | | | | | | | | |
| in € thousand | Note | 2023 | 2022 | 2021 | ||||
| Revenue | 7 | 90,246 | 95,058 | 39,481 | ||||
| Cost of sales | 7 | (63,849) | (61,721) | (30,506) | ||||
| Gross profit | | | 26,397 | 33,337 | 8,975 | |||
| Selling | 8 | (12,577) | (11,369) | (7,851) | ||||
| General administration | 9 | (12,538) | (6,973) | (6,298) | ||||
| Research and development | 10 | (5,148) | (4,818) | (2,733) | ||||
| Other income | 11 | 15,985 | 3,375 | 1,924 | ||||
| Other expenses | 12 | (2,620) | (2,988) | (4,779) | ||||
| (Impairment) / Reversal on impairment on financial assets | 13 | 22,696 | 3,091 | 3,333 | ||||
| Operating profit (loss) | | | 32,195 | 13,654 | (7,427) | |||
| Finance income | | 19,685 | 5,758 | 3,360 | ||||
| Finance expenses | | | (10,091) | (17,746) | (18,014) | |||
| Financial result | 14 | | 9,594 | (11,988) | (14,654) | |||
| Share of profit (loss) in joint ventures | 15 | (1,057) | — | — | ||||
| Income (loss) before income tax | | | 40,732 | 1,667 | (22,082) | |||
| Income tax benefit (expense) | 16 | (2,778) | 1,924 | (5,195) | ||||
| Net income (loss) for the period | | | 37,954 | 3,591 | (27,277) | |||
| Other comprehensive income (loss) that may be reclassified to profit or loss | | | (1,625) | (503) | 130 | |||
| Exchange differences on translation of foreign business units | 26 | (1,625) | (503) | 130 | ||||
| Items that will not be subsequently reclassified to profit or loss | | | 18 | 213 | 20 | |||
| Remeasurement of defined pension benefit obligation | 30 | 25 | 300 | 28 | ||||
| Income tax on remeasurement of defined pension benefit obligation | | | (7) | (88) | (8) | |||
| Other comprehensive income (loss) | | | (1,607) | (290) | 150 | |||
| Total combined comprehensive income (loss) for the reporting period | | | 36,346 | 3,301 | (27,127) | |||
| Net income (loss) attributable to | | | ||||||
| Owners of SCHMID | | | 36,868 | 1,550 | (24,452) | |||
| Non-controlling interests | | | 1,086 | 2,041 | (2,825) | |||
| Total combined comprehensive income (loss) attributable to | | | ||||||
| Owners of SCHMID | | | 35,669 | 1,456 | (24,597) | |||
| Non-controlling interests | | | 677 | 1,845 | (2,530) |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | Year Ended | ||||||||
| | | Year Ended December 31, 2023 | | | | | | | | | | December 31, 2023 | ||||
| | | | | | | | IFRS Policy and | | | | | | | | | |
| | | | | Pegasus (US | | Presentation | | Transaction | | | | | | |||
| | | Schmid (IFRS, | | GAAP, As | | Alignment | | Accounting | | | | | Pro Forma | |||
| | Historical) | | Converted) | (Note 2) | Adjustments | | | Combined | ||||||||
| Revenue | | 90,246 | | € | | € | | € | | | | | € 9,506 | |||
| Cost of sales | | (63,849) | | — | | | | | | | (63,849) | |||||
| Gross Profit | | 26,397 | | — | | — | | — | | | | 26,397 | ||||
| | | | | | | | | | | | | | | | | |
| Selling | | (12,577) | | — | | — | | — | | | | (12,577) | ||||
| General administration | | (12,538) | | (751) | | — | | 155 | BB | | (87,424) | |||||
| | | | | | | | | | | (4,184) | | CC | | | | |
| | | | | | | | | | | (70,106) | | DD | | | | |
| Research and development | | (5,148) | | — | | — | | — | | | | (5,148) | ||||
| Other income | | 15,985 | | — | | — | | — | | | | 15,985 | ||||
| Other expenses | | (2,620) | | — | | — | | — | | | | (2,620) | ||||
| Listing fee amortization expense | | — | | (89) | | — | | — | | | | (89) | ||||
| Legal and accounting expense | | — | | (4,957) | | — | | — | | | | (4,957) | ||||
| Insurance expense | | — | | (181) | | — | | — | | | | (181) | ||||
| (Impairment) / Reversal on impairment on financials assets | | 22,696 | | — | | — | | — | | | | 22,696 | ||||
| Operating profit (loss) | | 32,195 | | (5,978) | | — | | (74,135) | | | | (47,918) | ||||
| | | | | | | | | | | | | | | | | |
| Finance income | | 19,685 | | — | | — | | — | | 19,685 | ||||||
| Interest and dividend income on cash and marketable securities held in Trust Account | | — | | 4,851 | | — | | (4,851) | AA | | — | |||||
| Change in fair value of warrant liabilities | | — | | (1,251) | | — | | (204) | EE | | (1,455) | |||||
| Loss on foreign exchange conversion | | — | | (33) | | — | | — | | | | (33) | ||||
| Finance expense | | (10,091) | | — | | — | | (1,508) | FF | | (11,599) | |||||
| Financial result | | 9,594 | | 3,567 | | — | | (6,563) | | | | 6,598 | ||||
| | | | | | | | | | | | | | | | | |
| Share of profit(loss) in joint venture | | (1,057) | | — | | — | | — | | | | — | ||||
| Income (loss) before income tax | | 40,732 | | (2,411) | | — | | (80,698) | | | | (42,378) | ||||
| | | | | | | | | | | | | | | | | |
| Income tax expense | | (2,778) | | — | | — | | — | | | | (2,778) | ||||
| Net income (loss) for the period | | 37,954 | | (2,411) | | — | | (80,698) | | | | (45,156) | ||||
| | | | | | | | | | | | | | | | | |
| Other comprehensive income (loss) | | (1,607) | | — | | — | | — | | | | (1,607) | ||||
| Total comprehensive income | | 36,346 | | (2,411) | | — | | (80,698) | | | | (46,763) | ||||
| | | | | | | | | | | | | | | | | |
| Total Comprehensive income (loss) attributable to | | | | | | | | |||||||||
| Owners of Schmid Group | | 35,669 | | — | | — | | 35,669 | | | | — | ||||
| Owners of TopCo | | — | | — | | — | | (47,277) | | | | (47,277) | ||||
| Non-controlling interest | | 677 | | — | | — | | (163) | GG | | 514 | |||||
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Pro forma weighted average ordinary shares outstanding – basic and diluted | | | | | | | 37,974,862 | |||||||||
| Pro forma net loss per share – basic and diluted | | | | | | | € | -1.189 | ||||||||
| | | | | | ||||
| | | Year Ended | ||||||
| | | December 31, | ||||||
| | | 2023 | | 2022 | ||||
| | | (in € thousands) | ||||||
| Statements of Profit or Loss Data | ||||||||
| Revenue | 90,246 | 95,058 | ||||||
| Cost of sales | (63,849) | (61,721) | ||||||
| Gross profit | 26,397 | 33,337 | ||||||
| Selling | (12,577) | (11,369) | ||||||
| General administration | (12,538) | (6,973) | ||||||
| Research and development | (5,148) | (4,818) | ||||||
| Other income | 15,985 | 3,375 | ||||||
| Other expenses | (2,620) | (2,988) | ||||||
| Reversal on impairment on financial assets, net | 22,696 | 3,091 | ||||||
| Operating profit | 32,195 | 13,654 | ||||||
| Financial result | 9,594 | (11,988) | ||||||
| Share of profit (loss) in joint ventures | | (1,057) | | — | ||||
| Income before income tax | 40,732 | 1,667 | ||||||
| Income tax (expense) benefit | (2,778) | 1,924 | ||||||
| Net income for the period | 37,954 | 3,591 | ||||||
| | | | | | | |
| in € thousand | 2023 | 2022 | 2021 | |||
| Personnel expenses | (2,261) | (1,888) | (1,319) | |||
| Depreciation/amortization | (877) | (910) | (627) | |||
| Legal and consulting fees | (587) | (614) | (422) | |||
| R&D related external administration | (906) | (856) | (282) | |||
| Other research and development expenses | (517) | (549) | (83) | |||
| Total research and development expenses | (5,148) | (4,818) | (2,733) |
